The following summarizes some of the highlights from Day 2 if the Americas Committee for Treatment and Research in MS (ACTRIMS) Forum 2025.
Latest News
ACTRIMS Forum 2025 Highlights – Friday, February 28, 2025
February 28, 2025The following summarizes some of the highlights from Day 1 of the Americas Committee for Treatment and Research in MS (ACTRIMS) Forum 2025.
CLINICAL CASES IN MS: A 38-YEAR-OLD WOMAN PLANNING PREGNANCY
February 27, 2025Click here to watch Dr. Kristen Krysko discuss the case and the responses to the survey.
RJ, age 38 years, has a 15-year history of relapsing-remitting multiple sclerosis. She initially presented with highly-active MS and was started on beta-interferon-1a 44µg. She continued to have significant clinical disease activity and ongoing MRI lesions in both brain and spine. She was transitioned to fingolimod in 2012. Read More
sNfL useful in prognosis for first demyelinating event
February 20, 2025A new study reports that obtaining neurofilament-light chain levels in patients with a first demyelinating event is useful to identify those at risk of developing multiple sclerosis (Cornabella et al. Neurol Neuroimmunol Neuroinflamm 2025;12:e200370). Read More